Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4660

Next 25
Website Changes
09/01/2015 UCLA Researchers Develop a Likely New Combo Treatment for the Deadliest Form of Brain Cancer
09/01/2015 Oncoceutics Awarded Grant for Phase II Brain Cancer Trial
08/31/2015 IBTA Newsletter
08/29/2015 Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
08/26/2015 WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials
08/26/2015 Enrollment Begins In Expansion Phase of ONC201 Clinical Trial
08/26/2015 Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.
08/25/2015 FDA Grants Orphan Drug Designation for Tocagen`s Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma
08/24/2015 ?Celldex and the limits of ‘overall survival benefit’ in cancer trials
08/24/2015 Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement
08/24/2015 NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing Patients In Trial Continuing To Be Treated Per Protocol, Including In Germany
08/24/2015 Update posted for Ben Williams` "Treatment Options for Glioblastoma and other Gliomas"
08/17/2015 San Diego couple trying to stop time with Novocure
08/17/2015 Added survivor story Debbie - 10 year GBM survivor!
08/14/2015 Cleveland Clinic researcher awarded National Cancer Institute`s Outstanding Investigator Award
08/14/2015 ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma
08/12/2015 Can a Lung Cancer Drug Fight Brain Tumors?
08/09/2015 Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
08/05/2015 Colchicine derivative as a potential anti-glioma compound.
08/05/2015 Musella Foundation Copayment Assistance Program is now closed to new patients
08/05/2015 IBTA e-News
07/27/2015 Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use
07/27/2015 A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
07/18/2015 Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis.
07/18/2015 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites